BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28138305)

  • 21. A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei.
    Gilbreath JJ; Semino-Mora C; Friedline CJ; Liu H; Bodi KL; McAvoy TJ; Francis J; Nieroda C; Sardi A; Dubois A; Lazinski DW; Camilli A; Testerman TL; Merrell DS
    Orphanet J Rare Dis; 2013 Jul; 8():105. PubMed ID: 23844722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
    Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
    J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major secretory mucin expression in chronic sinusitis.
    Ali MS; Hutton DA; Wilson JA; Pearson JP
    Otolaryngol Head Neck Surg; 2005 Sep; 133(3):423-8. PubMed ID: 16143194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: JSLS. 2009;13(2):203-206 Laparoscopic mucin removal in patients with pseudomyxoma peritonei.
    Albedah A
    JSLS; 2010; 14(1):152; author reply 152-3. PubMed ID: 20529543
    [No Abstract]   [Full Text] [Related]  

  • 26. Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei.
    Villarejo-Campos P; García-Arranz M; Qian S; Jiménez de Los Galanes S; Domínguez-Prieto V; Vélez-Pinto JF; Guijo Castellano I; Jiménez-Fuertes M; Guadalajara H; García-Olmo D
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei.
    Pillai K; Akhter J; Chua TC; Morris DL
    J Surg Res; 2012 May; 174(2):e69-73. PubMed ID: 22261589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth.
    Dilly AK; Song X; Zeh HJ; Guo ZS; Lee YJ; Bartlett DL; Choudry HA
    Transl Res; 2015 Oct; 166(4):344-54. PubMed ID: 25890193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucin as a therapeutic target in pseudomyxoma peritonei.
    Choudry HA; O'Malley ME; Guo ZS; Zeh HJ; Bartlett DL
    J Surg Oncol; 2012 Dec; 106(7):911-7. PubMed ID: 22585683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycomic Profiling Highlights Increased Fucosylation in Pseudomyxoma Peritonei.
    Saarinen L; Nummela P; Leinonen H; Heiskanen A; Thiel A; Haglund C; Lepistö A; Satomaa T; Hautaniemi S; Ristimäki A
    Mol Cell Proteomics; 2018 Nov; 17(11):2107-2118. PubMed ID: 30072579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed nasal mucus as a model for sinus mucin gene expression studies.
    Ali MS; Wilson JA; Pearson JP
    Laryngoscope; 2002 Feb; 112(2):326-31. PubMed ID: 11889392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.
    Mohamed F; Gething S; Haiba M; Brun EA; Sugarbaker PH
    J Surg Oncol; 2004 Apr; 86(1):10-5. PubMed ID: 15048674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa.
    Martínez-Antón A; Debolós C; Garrido M; Roca-Ferrer J; Barranco C; Alobid I; Xaubet A; Picado C; Mullol J
    Clin Exp Allergy; 2006 Apr; 36(4):448-57. PubMed ID: 16630149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms.
    Chang MS; Byeon SJ; Yoon SO; Kim BH; Lee HS; Kang GH; Kim WH; Park KJ
    Pathobiology; 2012; 79(1):45-53. PubMed ID: 22236547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro.
    Chorley BN; Crews AL; Li Y; Adler KB; Minnicozzi M; Martin LD
    Respir Res; 2006 Feb; 7(1):35. PubMed ID: 16504136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.
    Lin YL; Ma R; Li Y
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2179-2188. PubMed ID: 32700107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
    Henke MO; John G; Germann M; Lindemann H; Rubin BK
    Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomyxoma peritonei: does a true mucolytic agent exist? In vitro and in vivo studies.
    Shyr YM; Su CH; Wang HC; Lo SS; Lui WY
    Am Surg; 1995 Mar; 61(3):265-70. PubMed ID: 7887544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Biological Synthesis and the Function of Mucin 2 in Pseudomyxoma Peritonei.
    Lin YL; Li Y
    Cancer Manag Res; 2021; 13():7909-7917. PubMed ID: 34703312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.